Understanding the Patient Journey and Pain Points in Diagnosis

The Challenge

The Challenge

A biopharmaceutical company wants to shift patients indicated for their soon to be approved treatment from allergists/immunologists to oncologists across community practices.

The IP Solution

The IP Solution

IP supported the development and execution of a three-part advisory board series aimed at gaining an understanding of the community hospital landscape and gaining perspective across a variety of stakeholders. The issues addressed included best practices for patient identification and management, in consideration of strategies related to contracting, Electronic Medical Records, burden of disease, referral and site of care, and testing.

The Result

The Results

Insights regarding patient dynamics, symptom assessment, diagnostic workup and mutation testing, potential areas of education, and distribution, access and GPO contraction were collected from clinical pharmacists, community hematologists/ oncologists and executive/community practice leaders.

The company was able to use these results to share appropriate data and improve the presentation of key information to relevant stakeholders for disease diagnosis and for disease management.

Related Case Studies

Strategizing a Change in a Company’s Focus

A large, multinational pharmaceutical company was looking to incorporate the patient voice across all stages of product development for their entire portfolio of oncology/hematology products. Their team needed support from a partner with the expertise to reach patients and advocacy organizations, and to develop an overall strategy for their advocacy relations team.